SENSORA™ Cardiac Detection Platform

Detect More Valvular Heart Disease

SENSORA™ is the first AI-powered software that more than doubles structural murmur detection sensitivity1, giving you the power to optimize downstream care and improve outcomes.

An Early Detection Tool Designed for Structural Murmurs

More than half of clinically significant valvular heart disease is missed2. Now you can detect it earlier and more consistently, so your patients can get the treatment they need sooner.

Detect and Distinguish Structural Murmurs With a Stethoscope

Eko’s FDA-cleared platform3 is the first and only to identify structural murmurs with a digital stethoscope4.

Achieve Objective and Consistent Performance

SENSORA™ for structural murmur detection more than doubles the likelihood of detecting significant valvular heart disease1.

Small chart visualizing heart sounds

SENSORA™ Care Pathway Analytics

Care Pathway Analytics is designed to assist with critical decision-making by identifying care gaps within the patient's journey.

Health System Ready

Deploy and Train Quickly

Deployment is quick and easy. The system is simple to use, requiring minimal training.

Seamlessly Integrate in Your Workflow

The stethoscope is already part of your clinical workflow. Eko’s detection works with your routine patient exam.

Refer Appropriate Patients

Eko’s dashboard gives you a comprehensive view of patients with structural murmurs to help you view and manage referrals.

Join 100s of Thousands of Clinicians in the Fight Against Heart Disease

Eko helps healthcare professionals detect heart and lung disease earlier and with higher accuracy, diagnose with more confidence, manage treatment effectively, and ultimately give patients the best care possible.

Let’s Work Together

If you are at a hospital system in the US, contact us to learn how you can detect more valvular heart disease at your institution with Eko.

References

(1) Eko Murmur Analysis Software User Manual, LBL 295, Rev B. Structural murmur identification adult patients (>18 years old)
(2) d’Arcy et al. Eur Heart J 2016;37:3515–3522. doi:10.1093/eurheartj/ehw229
(3) FDA Clears Eko’s Heart Disease Detection AI for Adults and Pediatrics
(4) Contact Sales to learn more about SENSORA™
(5) Gardezi SKM, et al. Cardiac auscultation poorly predicts the presence of valvular heart disease in asymptomatic primary care patients, Heart 2018;104:1832–1835. doi:10.1136/heartjnl-2018-313082